Affiliations: [a] Human, Social and Health Department, University of Cassino and Southern Lazio, V.S. Angelo, Loc. Folcara, Cassino (FR), Italy | [b] Biochemistry and Clinical Biochemistry Institute, Catholic University, School of Medicine, Rome, Italy | [c] Istituto di Chimica del Riconoscimento Molecolare (ICRM), National Research Council (CNR), Rome, Italy
Correspondence:
[*]
Correspondence to: Francesco Misiti, Department of Human Sciences, Society and Health University of Cassino and Southern Lazio, Italy V.S. Angelo-Polo didattico della Folcara Cassino (FR) 03043, Italy. Tel.: +39 7762994423; f.misiti@unicas.it
Abstract: We have previously showed that morphological alterations in Red Blood Cells (RBCs) are correlated to an impaired eNOS enzymatic activity and a concomitant reduced NO derived metabolites formation. Here we extend our previous observations, reporting that RBC morphology is regulated by a series of specific cell signaling events linked to Protein Kinase C (PKC)-mediated activation of caspase 3. Pretreatment of RBCs with the PKC inhibitor chelerythrine, prior to the addition of phorbol-12-myristate-13-acetate (PMA), an activator of PKC, blocks the appearance of the morphology alterations and the sustained decrease in nitrates and nitrites levels induced by PMA. Inhibition of PKC also completely inhibits PMA mediated caspase-3 activation. On the other hand, caspase 3 inhibition, lessens the PMA induced-effects on the appearance of RBC morphology alterations, although it enhances PMA-mediated effects on nitric oxide (NO) derived metabolites levels. These data demonstrate that PKC-mediated activation of caspase 3 is an integral and essential part of signaling pathway in RBCs, that may be a regulatory factor of RBC mechanical properties, through regulation of NO metabolism.
